| 发明名称 |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY |
| 摘要 |
This invention relates to pharmaceutical compositions comprising 5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole (C1100), to processes for preparing the compositions, and to various therapeutic uses of the combinations. Also provided is a method of treatment of Duchenne muscular dystrophy or Becker muscular dystrophy using the compositions. |
| 申请公布号 |
EP2846774(A1) |
申请公布日期 |
2015.03.18 |
| 申请号 |
EP20130726699 |
申请日期 |
2013.05.10 |
| 申请人 |
SUMMIT CORPORATION PLC |
发明人 |
TINSLEY, JONATHON, MARK;ROBINSON, NEIL |
| 分类号 |
A61K9/14;A61K9/00;A61K9/10;A61K31/423;A61K47/10;A61K47/14;A61K47/26;A61K47/36;A61K47/38;A61P21/00 |
主分类号 |
A61K9/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
